Terms: = Leukemia AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras
532 results:
1. Mechanisms for regulation of RAS palmitoylation and plasma membrane trafficking in hematopoietic malignancies.
Yu F; Qian Z
J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37317974
[TBL] [Abstract] [Full Text] [Related]
2. Identification of crucial genes involved in thyroid cancer development.
Kalarani IB; Sivamani G; Veerabathiran R
J Egypt Natl Canc Inst; 2023 May; 35(1):15. PubMed ID: 37211566
[TBL] [Abstract] [Full Text] [Related]
3. A Drosophila chemical screen reveals synergistic effect of MEK and DGKα inhibition in Ras-driven cancer.
La Marca JE; Ely RW; Diepstraten ST; Burke P; Kelly GL; Humbert PO; Richardson HE
Dis Model Mech; 2023 Mar; 16(3):. PubMed ID: 36861754
[TBL] [Abstract] [Full Text] [Related]
4. Targeting k-ras Mutations Show Promise Towards Ending Ras's "Undruggable" Era.
Adams PD; Muhoza D
Protein Pept Lett; 2022; 29(12):1007-1015. PubMed ID: 36200189
[TBL] [Abstract] [Full Text] [Related]
5. [The Effect of KRAS on Proliferation and Apoptosis of T-ALL Cell Lines].
Liu ZY; Shu Y; Fu G; Su HY; Zhu D; Zeng LM; Ma DY; Zou L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1040-1048. PubMed ID: 35981360
[TBL] [Abstract] [Full Text] [Related]
6. Strategies for Targeting KRAS: A Challenging Drug Target.
Wadood A; Ajmal A; Rehman AU
Curr Pharm Des; 2022; 28(23):1897-1901. PubMed ID: 35524675
[TBL] [Abstract] [Full Text] [Related]
7. Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating n-ras/ERK pathway.
Sofi MH; Tian L; Schutt S; Khan I; Choi HJ; Wu Y; Bastian D; Ticer T; Kassir MF; Atilgan FC; Kim J; Sui X; Zivkovic A; Mehrotra S; O'Bryan JP; Stark H; Martin PJ; Ogretmen B; Yu XZ
Leukemia; 2022 Jul; 36(7):1907-1915. PubMed ID: 35513703
[TBL] [Abstract] [Full Text] [Related]
8. Hoxa11-mediated reduction of cell migration contributes to myeloid sarcoma formation induced by cooperation of MLL/AF10 with activating KRAS mutation in a mouse transplantation model: Hoxa11 in myeloid sarcoma formation.
Fu JF; Wen CJ; Yen TH; Shih LY
Neoplasia; 2022 Jul; 29():100802. PubMed ID: 35500545
[TBL] [Abstract] [Full Text] [Related]
9. [Clinical Characteristics and Prognosis of Acute Myeloid leukemia Patients with inv(16)/t(16;16)(p13.1;q22) and/or CBFβ-MYH11].
Wang YM; Cai P; Zhou MJ; Gong YY; Pan JL; Cen JN; Yang XF; Chen SN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):. PubMed ID: 35400360
[TBL] [Abstract] [Full Text] [Related]
10. Differential proteome and functional analysis of NSCLC cell lines in response to Tualang honey treatment.
Amran N; Abdul-Rahman PS
J Ethnopharmacol; 2022 Jul; 293():115264. PubMed ID: 35398242
[TBL] [Abstract] [Full Text] [Related]
11. [Clinical Characteristics and Prognosis of Acute Myeloid leukemia Patients with inv(16)/t(16;16)(p13.1;q22) and/or CBFβ-MYH11].
Wang YM; Cai P; Zhou MJ; Gong YY; Pan JL; Cen JN; Yang XF; Chen SN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):367-372. PubMed ID: 35395965
[TBL] [Abstract] [Full Text] [Related]
12. The role of TBK1 in cancer pathogenesis and anticancer immunity.
Runde AP; Mack R; S J PB; Zhang J
J Exp Clin Cancer Res; 2022 Apr; 41(1):135. PubMed ID: 35395857
[TBL] [Abstract] [Full Text] [Related]
13. Optimized outcome prediction of oncogenetic mutations in non-early T-cell precursor acute lymphoblastic leukemia.
Peng LJ; Wang SS; Guo SS; Zhang JJ; Liu YF; Rousseaux S; Khochbin S; Chen B; Wang J; Mi JQ
Immunobiology; 2022 May; 227(3):152205. PubMed ID: 35279479
[TBL] [Abstract] [Full Text] [Related]
14. Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia.
Hortal AM; Oeste CL; Cifuentes C; Alcoceba M; Fernández-Pisonero I; Clavaín L; Tercero R; Mendoza P; Domínguez V; García-Flores M; Pintado B; Abia D; García-Macías C; Navarro-Bailón A; Bustelo XR; González M; Alarcón B
Mol Cancer; 2022 Feb; 21(1):35. PubMed ID: 35120522
[TBL] [Abstract] [Full Text] [Related]
15. Rapid Detection of n-ras Gene Common Mutations in Acute Myeloid leukemia (AML) Using High Resolution Melting (HRM) Method.
Zaka Khosravi S; Moonesi M; Moradabadi A; Rajaeinejad M; Heidari MF; Noroozi-Aghideh A
Asian Pac J Cancer Prev; 2022 Jan; 23(1):125-130. PubMed ID: 35092380
[TBL] [Abstract] [Full Text] [Related]
16. Mutated RAS-associating proteins and ERK activation in relapse/refractory diffuse large B cell lymphoma.
Benoit A; Bou-Petit E; Chou H; Lu M; Guilbert C; Luo VM; Assouline S; Morin RD; Dmitrienko S; Estrada-Tejedor R; Johnson NA; Mann KK
Sci Rep; 2022 Jan; 12(1):779. PubMed ID: 35039569
[TBL] [Abstract] [Full Text] [Related]
17. Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement.
Di Giacomo D; Quintini M; Pierini V; Pellanera F; La Starza R; Gorello P; Matteucci C; Crescenzi B; Fiumara PF; Veltroni M; Borlenghi E; Albano F; Forghieri F; Maccaferri M; Bettelli F; Luppi M; Cuneo A; Rossi G; Mecucci C
Ann Hematol; 2022 Feb; 101(2):297-307. PubMed ID: 34859285
[TBL] [Abstract] [Full Text] [Related]
18. [Clinical Characteristics of Acute Myeloid leukemia Patients with RUNX1 Gene Mutation].
Ni ZF; Ma LJ; Shi LL; Shen PL; Zhao JQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1411-1416. PubMed ID: 34627418
[TBL] [Abstract] [Full Text] [Related]
19. PAX3/7-FOXO1 fusion-negative alveolar rhabdomyosarcoma in Schuurs-Hoeijmakers syndrome.
Ohkawa T; Nishimura A; Kosaki K; Aoki-Nogami Y; Tomizawa D; Kashimada K; Morio T; Kato M; Mizutani S; Takagi M
J Hum Genet; 2022 Jan; 67(1):51-54. PubMed ID: 34341476
[TBL] [Abstract] [Full Text] [Related]
20. Vitexin isolated from Prosopis cineraria leaves induce apoptosis in K-562 leukemia cells via inhibition of the BCR-ABL-Ras-Raf pathway.
Sarkar MK; Kar A; Jayaraman A; Kar Mahapatra S; Vadivel V
J Pharm Pharmacol; 2022 Jan; 74(1):103-111. PubMed ID: 34109977
[TBL] [Abstract] [Full Text] [Related]
[Next]
